OptimizeRx Corp (NAS:OPRX)
$ 10.54 -0.27 (-2.5%) Market Cap: 191.66 Mil Enterprise Value: 219.54 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 77/100

Q2 2021 OPTIMIZERx Corp Earnings Call Transcript

Aug 04, 2021 / 08:30PM GMT
Release Date Price: $57.47 (+3.03%)
Operator

Good afternoon, and thank you for joining OptimizeRx Corporation's Second Quarter Fiscal 2021 Earnings Call. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Company Chief Financial Officer, Doug Baker; and Chief Commercial Officer, Stephen Silvestro.

Before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during today's call. I would like to remind everyone that today's call is being recorded and will be made available for replay via webcast only with instructions in today's press release and in the Investors section of the company's website.

Now I'd like to turn the call over to OptimizeRx CEO, William Febbo. Sir, please go ahead.

William J. Febbo
OptimizeRx Corporation - CEO & Director

Thank you, Melinda. Good afternoon. Before we begin our review of the quarter, we just wanted to express our warm wishes to everyone on the call today. I hope that you're all having an enjoyable summer in retrospect of all that has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot